The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) is the largest international HIV clinical research unit within the Thai Red Cross AIDS Research Centre. It was established in 1996 as a collaboration between the TRC-ARC, the Kirby Institute of Infections and Immunity in Society/University of New South Wales in Sydney, Australia and the Amsterdam institute in Global Health and Development in Amsterdam, The Netherlands. HIV-NAT has been in the forefront in the field of HIV clinical research in Thailand and in the SEA region. HIV-NAT currently has 120 staff members.
Praphan Phanuphak, MD, PhD
is a specialist in immunology, microbiology, and internal medicine. He directs the TRC-ARC, and is Co-Director of its subsidiary, HIV-NAT. Dr. Phanuphak has managed HIV-infected patients and conducted HIV research since diagnosing and reporting the first case of AIDS acquired in Thailand. He was godfather of both the TRC-ARC and its Anonymous Clinic, founded upon his initiative by the TRCS in 1989 and 1991, respectively. In the mid-1990s, he conducted the first clinical trial in Thailand of an AIDS vaccine. He has been PI on numerous internationally-funded HIV studies.
Kiat Ruxrungtham, MD, MSc
has been since 1996 the Deputy Director of HIV-NAT and Director of its joint HIV-NAT/Chulalongkorn Clinical Research Laboratory. He also serves as Deputy Director of the Thai Red Cross AIDS Research Centre. Dr. Ruxrungtham has more than 25 years of clinical research experience in the field of HIV and immunology, including serving as PI for more than 40 studies. He has published more than 210 papers in peer-reviewed journals. In 2011, he received the prestigious “Outstanding Researcher Award” from the National Research Council of Thailand.
Jintanat Ananworanich, MD, Ph.D.
is the Deputy Director of Scientific Affairs at HIV-NAT, Thai Red Cross AIDS Research Centre. She also heads operations at SEARCH and holds the position of Associate Professor at the University of Hawaii. Dr. Ananworanich has expertise in developing protocols and managing adult and pediatric HIV clinical trials involving international and national sites. She has been a trainer on HIV/AIDS issues particularly antiretroviral therapy and the treatment of children with HIV.
Anchalee Avihingsanon, MD
is a specialist in infectious diseases. She joined HIV-NAT in 2003 as a research physician, and since then she has led and coordinated over 40 clinical trials investigating various aspects of HIV. She is Thailand country coordinator for START and other INSIGHT Network studies, and is member of the INSIGHT Network Steering Committee. She obtained both Thai government and international funding to investigate research questions of relevance to Thailand and the region, including the pharmacokinetics of low dose antiretrovirals, and studies of tuberculosis, hepatitis B and C, and HIV renal disease. Dr. Avihingsanon has been Chief of the HIV-NAT Medical Department since 2009. She is on the writing committee for Thai HIV Treatment Guidelines, and a member of Track B planning the 2013 International Congress on AIDS in Asia and the Pacific. She advises the TRC-ARC’s Community Advisory Board (CAB).
Thanyawee Puthanakit, MD, MHS
is a pediatric infectious disease specialist and also holds the position of Associate Professor at Chulalongkorn University. She trained in clinical investigations at the Johns Hopkins Bloomberg School of Public Health and began work at HIV-NAT as a research physician in 2006. Since then, she has coordinated the CIPRA program in Thailand and Cambodia, the PREDICT study and substudies, plus others totaling 30 in all. Since 2005, she has been a member of the WHO Pediatric Antiretroviral Treatment Guidelines Writing Committee. From 2009 to 2010, she served on the Scientific Oversight Committee of the IMPAACT Network. Dr. Puthanakit’s research focus is childhood vaccines, for which she has conducted ten immunogenicity trials in both HIV-infected and uninfected children.
Stephen Kerr, MIPH, PhD
is the Head of the Biostatistics Department at HIV-NAT. He has a background in pharmacology and pharmacoepidemiology, and holds a joint Faculty position at the Kirby Institute, University of New South Wales in Sydney, Australia. He liaises with study sponsors, principal investigators and DSMB’s to coordinate bio-statistical aspects of study development and analyses for TRC-ARC.
Torsak Bunupuradah, MD
is a specialist in Allergy and Immunology. A Clinical Trial Physician and Pediatrician at HIV-NAT, Dr. Bunupuradah has more than 7 years of experience in conducting pediatric HIV clinical studies.
Wasana Prasitsuebsai, MD
is Clinical Research Physician and Pediatrician with many years of experience in pediatric HIV clinical research. She has led several studies including TASER-Pediatrics and PREDICT cohort and substudies.
Sasiwimol Ubolyam, MSc
is the Head of the HIV-NAT/Chulalongkorn Clinical Research Laboratory. She has over 15 years of experience supervising the laboratory in compliance with Good Clinical Laboratory Practices (GCLP). She is the laboratory core leader for NIAID INSIGHT network and the CIPRA network studies.
Tulathip Suwanlerk, BNS
joined the TRC-ARC HIV-NAT in 2006 as a registered nurse to work on the PREDICT study, gaining experience since then in study recruitment, MedDRA coding, GCP, and many other aspects of clinical HIV research. Since 2009, she has headed the HIV-NAT Clinical Research Associate (CRA) Department and is responsible for coordinating clinical studies.
Thidarat Jupimai, MSc
is the Deputy Head of the CRA Department at HIV-NAT, and Head of its Regulatory and Quality Subunit. She has 12 years of clinical research experience and has been the CRA for several important studies.
Chavalun Ruengpanyathip, MSc
is the Head of the Data Management and Information Technology (IT) Department at HIV-NAT since 2009. He has over 16 years of experience in the data management and IT field and has been responsible for developing and maintaining the electronic database system for TRC-ARC and multi-site studies.
Plengsri Lertarrom, BPharm
is the Head of the Pharmacy Department at HIV-NAT. She has 26 years of experience as a registered pharmacist including 6 years in HIV clinical research. She is familiar with the pharmacy guidelines and instructions for DAID clinical trial network.
Supalak Phonphithak, MA
heads the Department of Clinical Study Nurse at HIV-NAT. She has a long experience in clinical research and patient care and currently supervises 20 study nurses and assistants.
Chuleeporn Wongvoranet, MA
is the Deputy Head of Clinical Study Nurse. She has many years of experience in clinical research and patient care. She had worked in one of Thailand’s best university hospitals before joining HIV-NAT in 2008.
Wanida Thianguankul, BNS
is the Deputy Head of Clinical Study Nurse. She has more than 5 years of experience in clinical research and patient care. She joined HIV-NAT as a study nurse in 2007.
Kesdao Nanthapisal, MCom
is the financial controller with vast experience in project accounting and financial management. She has joined HIV-NAT in 2000, and overseen budget and financial management for over 50 studies.
Jeerakan Janhom, BBA
is the Human Resources Coordinator & Head of Office Operations. She oversees day-to-day administrative and HR operations at HIV-NAT. Ms. Janhom joined us in 1998.
Praneet Moilanen, MNS
serves as Training Coordinator. She ensures the provision of capacity building for HIV-NAT staff, and organizes and coordinates local and regional HIV/AIDS trainings for health care professionals in collaboration with external organizations. Ms. Pinklow is an occupational health nurse and was a clinical research associate (CRA) at HIV-NAT for several years before taking up the Training Coordinator role in 2011.